Biblio

Phadke I, Dwivedi A, Taylor N. Turning the tide: From fibrosis to regeneration following anti-fibrogenic cell vaccination. Cell Stem Cell. 2022;29(10):1421-1423.

• PubMed
• Google Scholar

Wang X, Qi X, Guo X. Tusanqi-Related Sinusoidal Obstruction Syndrome in China: A Systematic Review of the Literatures. Medicine (Baltimore). 2015;94(23):e942.

• PubMed
• Google Scholar

Huang G, Wang M, Li X, Wu J, Chen S, Du N, Li K, Wang J, Xu C, Ren H, et al. TUSC7 suppression of Notch activation through sponging MiR-146 recapitulated the asymmetric cell division in lung adenocarcinoma stem cells. Life Sci. 2019:116630.

• PubMed
• Google Scholar

Yang L, Wang J, Altreuter J, Jhaveri A, Wong CJ, Song L, Fu J, Taing L, Bodapati S, Sahu A, et al. Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA. Nat Protoc. 2023.

• PubMed
• Google Scholar

Liu W, Gao L, Hou X, Feng S, Yan H, Pan H, Zhang S, Yang X, Jiang J, Ye F, et al. TWEAK Signaling-Induced ID1 Expression Drives Malignant Transformation of Hepatic Progenitor Cells During Hepatocarcinogenesis. Adv Sci (Weinh). 2023:e2300350.

• PubMed
• Google Scholar

Short C, Zhong A, Xu J, Mahdi E, Glazier A, Malkoff N, Noriega N, Yeo T, Asahina K, Wang K. TWEAK/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia. Hepatology. 2023.

• PubMed
• Google Scholar

Wyse RK, Isaacs T, Barker RA, Cookson MR, Dawson TM, Devos D, Dexter DT, Duffen J, Federoff H, Fiske B, et al. Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative. J Parkinsons Dis. 2024.

• PubMed
• Google Scholar

Liu Z, Xu C, Yu Y-K, Tu D-P, Peng Y, Zhang B. Twenty Years Development of Tibial Cortex Transverse Transport Surgery in PR China. Orthop Surg. 2022.

• PubMed
• Google Scholar

Ghavamzadeh A, Alimoghaddam K, Ghaffari F, Derakhshandeh R, Jalali A, Jahani M. Twenty years of experience on stem cell transplantation in iran. Iran Red Crescent Med J. 2013;15(2):93-100.

• PubMed
• Google Scholar

Regeenes R, Rocheleau JV. Twenty years of islet-on-a-chip: microfluidic tools for dissecting islet metabolism and function. Lab Chip. 2024.

• PubMed
• Google Scholar

Hägglund H, Remberger M, Ringden O. Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation. Bone Marrow Transplant. 2014.

• PubMed
• Google Scholar

Hashmi H, Bhandari S, Kumar R, Tripathi P, Rhodes JBlancett, Figg L, Baize T, Krem MM, Hegazi M, Emmons R. Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis. Hematol Oncol Stem Cell Ther. 2020.

• PubMed
• Google Scholar

Zarei-Ghanavati M, Rama P, Liu C. The twilight zone of stem cells and keratoprostheses. Ocul Surf. 2018.

• PubMed
• Google Scholar

Wang N, Yin J, You N, Zhu W, Guo N, Liu X, Zhang P, Huang W, Xie Y, Ren Q, et al. Twist family BHLH transcription factor 1 is required for the maintenance of leukemia stem cell in MLL-AF9+ acute myeloid leukemia. Haematologica. 2023.

• PubMed
• Google Scholar

Zhou M, Tang S, Zhang H, Yang L, Yang J, Liu M. [Twist gene promotes the formation and migration of mammospheres of BT-549 breast cancer cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015;31(3):321-4.

• PubMed
• Google Scholar

Khales SArdalan, Mozaffari-Jovin S, Geerts D, Abbaszadegan MReza. TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma. BMC Cancer. 2022;22(1):1272.

• PubMed
• Google Scholar

Voskamp C, Anderson LA, Koevoet WJ, Barnhoorn S, Mastroberardino PG, van Osch GJ, Narcisi R. TWIST1 controls cellular senescence and energy metabolism in mesenchymal stem cells. Eur Cell Mater. 2021;41:401-414.

• PubMed
• Google Scholar

Dragoi D, Krattenmacher A, Mishra VK, Schmidt JM, Kloos UJ, Meixner LK, Hauck SM, Buggenthin F, Schwartz D, Marr C, et al. Twist1 induces distinct cell states depending on TGFBR1-activation. Oncotarget. 2016.

• PubMed
• Google Scholar

Eguiarte-Solomon F, Blazanin N, Rho O, Carbajal S, Felsher DW, Tran PT, DiGiovanni J. Twist1 is required for the development of UVB-induced squamous cell carcinoma. Mol Carcinog. 2021.

• PubMed
• Google Scholar

Wang N, Guo D, Zhao YY, Dong CY, Liu X, Yang BX, Wang SW, Wang L, Liu QG, Ren Q, et al. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia. Oncotarget. 2015.

• PubMed
• Google Scholar

Oh BYoung, Kim S-Y, Lee YSong, Hong HKyung, Kim TWon, Kim SHyung, Lee WYong, Cho YBeom. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells. Oncotarget. 2016.

• PubMed
• Google Scholar

Yeeravalli R, Kaushik K, Das A. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis. Biochim Biophys Acta Mol Basis Dis. 2021:166141.

• PubMed
• Google Scholar

Kim JYong, Park M, Ohn J, Seong RHyun, Chung JHo, Kim KHan, Jo SJin, Kwon O. Twist2-driven chromatin remodeling governs the postnatal maturation of dermal fibroblasts. Cell Rep. 2022;39(7):110821.

• PubMed
• Google Scholar

Volta L, Manz MG. Twisted: Escape of epitope-edited healthy cells from immune attack. J Exp Med. 2023;220(12).

• PubMed
• Google Scholar

Niu H, Cancelas JA. Twisting the bone marrow stem cell niche. Haematologica. 2018;103(12):1937-1939.

• PubMed
• Google Scholar